Caldera Health is a biotechnology company with a vision to develop highly accurate prostate cancer diagnostic and prognostic tests. Their technology analyses gene expression levels of selected RNA biomarkers to diagnose prostate cancer and provide a prognosis of disease progression.
Caldera Health's founders were both diagnosed with metastatic prostate cancer, both due to the flaws of the PSA (prostate specific antigen) test and are in a unique position to answer the unmet clinical needs in prostate cancer diagnosis.
Students with an interest in medicine and biomedical technology will have the chance to work with a team that is using new technology to disrupt old diagnostic tests and provide solutions to their limitations.
For more information visit the official website at